Used in the synthesis of pharmaceuticals, particularly as a chiral intermediate in the production of dopamine agonists. It plays a key role in the development of drugs for the treatment of Parkinson’s disease, where its enantiomeric purity contributes to enhanced biological activity and reduced side effects. Its structure allows for selective interaction with neurotransmitter receptors, making it valuable in neuropharmacology research and the design of central nervous system-targeted therapeutics.